Ofatumumab added to dexamethasone in patients with relapsed of
refractory chronic lymphocytc leukemia. Results from a phase II
study of the czech leukemia study group for life

a 2013

Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life

DOUBEK, Michael, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, J. TRIZULJAK, Ludmila ŠEBEJOVÁ et. al.

Basic information

Original name

Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life

Authors

Edition

55th ASH Annual Meeting and Exposition, 2013

Other information

Language

English

Type of outcome

Konferenční abstrakt

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United States of America

Confidentiality degree

není předmětem státního či obchodního tajemství

Organization unit

Central European Institute of Technology

Tags

International impact, Reviewed

Změněno: 3/1/2014 10:54, Bc. Kateřina Kolesová

Citovat

DOUBEK, Michael, Yvona BRYCHTOVÁ, Anna PANOVSKÁ, J. TRIZULJAK, Ludmila ŠEBEJOVÁ, Olga STEHLÍKOVÁ, Jana CHOVANCOVÁ, Jitka MALČÍKOVÁ, Jana ŠMARDOVÁ, Karla PLEVOVÁ, Pavlína VOLFOVÁ, Martin TRBUŠEK, Marek MRÁZ, Denisa MAJERČÁKOVÁ, Petra OBRTLÍKOVÁ, Josef KARBAN, Lukáš SMOLEJ, Michaela LINDTNEROVÁ, Alexandra OLTOVÁ, Eva JELÍNKOVÁ, Šárka POSPÍŠILOVÁ and Jiří MAYER. Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life. In 55th ASH Annual Meeting and Exposition. 2013.

@proceedings{1138569,
   author = {Doubek, Michael and Brychtová, Yvona and Panovská, Anna and Trizuljak, J. and Šebejová, Ludmila and Stehlíková, Olga and Chovancová, Jana and Malčíková, Jitka and Šmardová, Jana and Plevová, Karla and Volfová, Pavlína and Trbušek, Martin and Mráz, Marek and Majerčáková, Denisa and Obrtlíková, Petra and Karban, Josef and Smolej, Lukáš and Lindtnerová, Michaela and Oltová, Alexandra and Jelínková, Eva and Pospíšilová, Šárka and Mayer, Jiří},
   booktitle = {55th ASH Annual Meeting and Exposition},
   language = {eng},
   title = {Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life},
   year = {2013}
}

TY  - CONF
ID  - 1138569
AU  - Doubek, Michael - Brychtová, Yvona - Panovská, Anna - Trizuljak, J. - Šebejová, Ludmila - Stehlíková, Olga - Chovancová, Jana - Malčíková, Jitka - Šmardová, Jana - Plevová, Karla - Volfová, Pavlína - Trbušek, Martin - Mráz, Marek - Majerčáková, Denisa - Obrtlíková, Petra - Karban, Josef - Smolej, Lukáš - Lindtnerová, Michaela - Oltová, Alexandra - Jelínková, Eva - Pospíšilová, Šárka - Mayer, Jiří
PY  - 2013
TI  - Ofatumumab added to dexamethasone in patients with relapsed of refractory chronic lymphocytc leukemia. Results from a phase II study of the czech leukemia study group for life
ER  -

Detailed Information on Publication Record